{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:05:22Z","timestamp":1792652722291,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.ejphar.2005.03.012","type":"journal-article","created":{"date-parts":[[2005,4,16]],"date-time":"2005-04-16T11:28:33Z","timestamp":1113650913000},"page":"173-179","source":"Crossref","is-referenced-by-count":84,"title":["Gentisic acid, an aspirin metabolite, inhibits oxidation of low-density lipoprotein and the formation of cholesterol ester hydroperoxides in human plasma"],"prefix":"10.1016","volume":"513","author":[{"given":"Keiko","family":"Ashidate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsunobu","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daigo","family":"Mimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisako","family":"Tohda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamio","family":"Teramoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yorihiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2005.03.012_bib1","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.CIR.101.10.1206","article-title":"Aspirin","volume":"101","author":"Awtry","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2005.03.012_bib2","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/1811199a0","article-title":"Antioxidant determinations by the use of a stable free radical","volume":"181","author":"Blois","year":"1958","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2005.03.012_bib3","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0022-2275(20)39807-2","article-title":"Preparative and quantitative isolation of plasma lipoproteins: rapid, single discontinuous density gradient ultracentrifugation in a vertical rotor","volume":"21","author":"Chung","year":"1980","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2005.03.012_bib4","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1016\/0006-2952(89)90681-3","article-title":"Hydroxylation of salicylate by activated neutrophils","volume":"38","author":"Davis","year":"1989","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.03.012_bib5","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3109\/10715768909073429","article-title":"Continuous monitoring of in vitro oxidation of human low density lipoprotein","volume":"6","author":"Esterbauer","year":"1989","journal-title":"Free Radic. Res. Commun."},{"key":"10.1016\/j.ejphar.2005.03.012_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0014-5793(00)01289-8","article-title":"The salicylate metabolite gentisic acid, but not the parent drug, inhibits glucose autoxidation-mediated atherogenic modification of low density lipoprotein","volume":"470","author":"Exner","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2005.03.012_bib7","doi-asserted-by":"crossref","first-page":"9748","DOI":"10.1073\/pnas.85.24.9748","article-title":"Antioxidant defenses and lipid peroxidation in human blood plasma","volume":"85","author":"Frei","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2005.03.012_bib8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/10715769409056582","article-title":"Human (THP-1) macrophages oxidize LDL by a thiol-dependent mechanism","volume":"21","author":"Graham","year":"1994","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.ejphar.2005.03.012_bib9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1042\/bj2370499","article-title":"Aromatic hydroxylation as a potential measure of hydroxyl-radical formation in vivo","volume":"237","author":"Grootveld","year":"1986","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2005.03.012_bib10","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/clinchem\/41.12.1819","article-title":"Lipid peroxidation and antioxidants as biomarkers of tissue damage","volume":"41","author":"Gutteridge","year":"1994","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ejphar.2005.03.012_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(98)00173-7","article-title":"Oxidants and antioxidants in pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis","volume":"141","author":"Heinecke","year":"1998","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2005.03.012_bib12","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S0014-5793(99)00043-5","article-title":"Salicylate inhibits LDL oxidation initiated by superoxide\/nitric oxide radicals","volume":"445","author":"Hermann","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2005.03.012_bib13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/bbrc.2000.3123","article-title":"Salicylate metabolites inhibit cyclooxygenase-2-dependent prostaglandin E2 synthesis in murine macrophages","volume":"274","author":"Hinz","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2005.03.012_bib14","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2337\/diabetes.39.11.1420","article-title":"Autoxidative glycosilation and possible involvement of peroxides and free radicals in LDL modification by glucose","volume":"39","author":"Hunt","year":"1990","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2005.03.012_bib15","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1172\/JCI117396","article-title":"Pathophysiological concentrations of glucose promote oxidative modification of low density lipoprotein by a superoxide-dependent pathway","volume":"94","author":"Kawamura","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2005.03.012_bib16","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S0140-6736(94)90656-4","article-title":"Inhibition of oxidation of low-density lipoprotein with red wine","volume":"344","author":"Kondo","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2005.03.012_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1749-6632.1993.tb38723.x","article-title":"Lipid peroxides as the initiating factor of atherosclerosis","volume":"676","author":"Naito","year":"1993","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2005.03.012_bib18","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2165\/00003088-198510020-00004","article-title":"Clinical pharmacokinetics of the salicylates","volume":"10","author":"Needs","year":"1985","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2005.03.012_bib19","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.4049\/jimmunol.138.7.2177","article-title":"Oxidation of salicylates by stimulated granulocytes: evidence that these drugs act as free radical scavengers in biological systems","volume":"138","author":"Sagone","year":"1987","journal-title":"J. Immunol."},{"key":"10.1016\/j.ejphar.2005.03.012_bib20","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/BF01062964","article-title":"Model representation of salicylate pharmacokinetics using unbound plasma salicylate concentrations and metabolite urinary excretion rates following a single oral dose","volume":"19","author":"Shen","year":"1991","journal-title":"J. Pharmacokinet. Biopharm."},{"key":"10.1016\/j.ejphar.2005.03.012_bib21","doi-asserted-by":"crossref","first-page":"20963","DOI":"10.1074\/jbc.272.34.20963","article-title":"Low density lipoprotein oxidation and its pathobiological significance","volume":"272","author":"Steinberg","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2005.03.012_bib22","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1056\/NEJM198904063201407","article-title":"Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity","volume":"320","author":"Steinberg","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2005.03.012_bib23","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0891-5849(87)80048-5","article-title":"Detection of lipid hydroperoxides and hydrogen peroxide at picomole levels by an HPLC and isoluminol chemiluminescence assay","volume":"3","author":"Yamamoto","year":"1987","journal-title":"Free Radic. Biol Med."},{"key":"10.1016\/j.ejphar.2005.03.012_bib24","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/0006-291X(89)92700-9","article-title":"Presence of cholesteryl ester hydroperoxide in human blood plasma","volume":"165","author":"Yamamoto","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2005.03.012_bib25","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1006\/abio.1997.2187","article-title":"Simultaneous detection of ubiquinol and ubiquinone in human plasma as a marker of oxidative stress","volume":"250","author":"Yamashita","year":"1997","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2005.03.012_bib26","unstructured":"Forth, W., Henschler, D., Rummel, W., 1987. Allgemeine und spezielle pharmakologie und toxikologie. Wien, Zurich: Wissenschaftsverlag, Mannheim."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299905002918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299905002918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T23:41:23Z","timestamp":1683070883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299905002918"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S0014299905002918"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2005.03.012","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}